Optical Coherence Tomography (OCT) Data Collection Study
NCT ID: NCT01459731
Last Updated: 2012-05-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
400 participants
OBSERVATIONAL
2011-09-30
2012-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Optical Coherence Tomography (OCT) Data Collection Study
NCT01641835
Data Collection of OCT and OCTA-based Ocular Measurements
NCT03887104
An Age-Stratified Data Collection Study to Establish a Normative Database Using the 3D Optical Coherence Tomography 3D OCT-1000 Mark II
NCT01027936
Performance Evaluation of OCT and OCT Angiography-based Ocular Measurements (Optical Coherence Tomography)
NCT04437082
Data Gathering for A10900
NCT07149740
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Age 18-29
No interventions assigned to this group
Age 30-39
No interventions assigned to this group
Age 40-49
No interventions assigned to this group
Age 50-59
No interventions assigned to this group
Age 60-69
No interventions assigned to this group
Age 70+
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Able and willing to provide consent
* Able and willing to complete the required examininations and visit
* Refractive error within 8 diopters sphere and within 2 diopters cylinder in each eye
* Best corrected visual acuity of 20/30 or better in each eye
Exclusion Criteria
* Concomitant use of hydroxycloroquine or chloroquine
* Family history of glaucoma among first degree relatives
* Intraocular pressure of 22mm Hg or greater in either eye
* Unreliable or abnormal visual field
* Active ocular disease
* Previously diagnosed with glaucoma or glaucoma suspect
* Congenital ocular abnormalities
* Previous intra-ocular surgery or laser treatment (other than refractive surgery or uncomplicated cataract surgery greater than 6 months previously)
* Anatomic narrow angle
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Optovue
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
George Comer, OD, MBA
Role: PRINCIPAL_INVESTIGATOR
Southern California College of Optometry at Marshall B. Ketchum University
Michael Chaglasian, OD
Role: PRINCIPAL_INVESTIGATOR
Illinois Eye Institute
Jorge Cuadros, OD, PhD
Role: PRINCIPAL_INVESTIGATOR
Buena Vista Eye Care
David Garway-Heath, MD
Role: PRINCIPAL_INVESTIGATOR
Institute of Ophthalmology, University College London
Pinakin G Davey, OD, PhD
Role: PRINCIPAL_INVESTIGATOR
Western University of Health Sciences
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Southern California College of Optometry
Fullerton, California, United States
College of Optometry, Western University of Health Sciences
Pomona, California, United States
Buena Vista Eye Care
San Jose, California, United States
Illinois Eye Institute
Chicago, Illinois, United States
Institute of Ophthalmology, University College London
London, England, United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
OCT 200-47091
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.